Global X Marijuana Life Sciences Index ETF (HMLSF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Global X Marijuana Life Sciences Index ETF (HMLSF) trades at $5.06 with AI Score 44/100 (Grade C). The Global X Marijuana Life Sciences Index ETF (HMLSF) provides investors with exposure to a diversified portfolio of companies in the North American cannabis industry. Market cap: $29.95M, Sector: Financial services.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for HMLSF: HMLSF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HMLSF against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HMLSF: the 1 perspectives are evenly split.
How is this calculated? →Global X Marijuana Life Sciences Index ETF (HMLSF) Financial Services Profile
The Global X Marijuana Life Sciences Index ETF (HMLSF) offers diversified exposure to the North American cannabis sector by tracking the Marijuana Index, mitigating single-security risks while capturing sector growth potential.
What Is the Investment Thesis for HMLSF?
The Global X Marijuana Life Sciences Index ETF (HMLSF) is positioned to benefit from the increasing acceptance and legalization of cannabis across North America, which is expected to drive significant growth in the sector. As of now, the ETF has a market capitalization of approximately $0.03 billion, indicating a niche but focused investment opportunity. The quarterly rebalancing of the fund ensures that it captures emerging leaders in the cannabis space, potentially enhancing returns as the market matures. Given the volatility of the cannabis industry, the diversified nature of HMLSF mitigates risks associated with individual stocks, providing a more stable investment vehicle. Key growth catalysts include regulatory changes favoring cannabis use, increased consumer demand, and advancements in cannabis-related technologies. However, investors should remain aware of ongoing regulatory risks and market volatility that could impact performance.
Based on FMP financials and quantitative analysis
HMLSF Key Highlights
- Market capitalization of approximately $0.03 billion reflects a focused niche in the cannabis investment space.
- Quarterly rebalancing ensures the ETF captures evolving market leadership in the cannabis sector.
- The fund aims to replicate the returns of the North American Marijuana Index, enhancing investor exposure to the sector.
- No dividend yield, indicating a focus on capital appreciation rather than income generation.
- Beta of 1.25 suggests higher volatility compared to the broader market.
Who Are HMLSF's Competitors?
HMLSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MJ Amplify Alternative Harvest ETF | $23.92 | -6.78% | $125.58M | — |
| CNBS Amplify Seymour Cannabis ETF | $27.56 | -4.27% | $83.44M | 44 |
| NXDT NexPoint Diversified Real Estate Trust | $5.53 | +3.08% | $285.77M | 73 |
| GENB Generate Biomedicines, Inc. | $17.03 | -2.18% | $2.18B | 72 |
| SII Sprott Inc. | $118.11 | +2.72% | $3.05B | 71 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.82 | +0.74% | $128.52M | 70 |
| TRNGF The Trendlines Group Ltd. | $0.03 | +2.95% | $28.87M | 62 |
| ARES Ares Management Corporation | $121.81 | +4.20% | $40.01B | 62 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HMLSF's Key Strengths?
- Diversified exposure to the cannabis sector mitigates individual stock risks.
- Quarterly rebalancing ensures alignment with market trends.
- Strong market positioning in a rapidly growing industry.
What Are HMLSF's Weaknesses?
- Small market capitalization may indicate liquidity concerns.
- No dividend yield limits income-generating potential for investors.
- Exposure to regulatory risks inherent in the cannabis industry.
What Could Drive HMLSF Stock Higher?
- Continued regulatory changes favoring cannabis legalization across North America.
- Growing consumer acceptance and demand for cannabis products.
- Quarterly rebalancing ensuring the ETF reflects current market leaders.
What Are the Key Risks for HMLSF?
- Regulatory challenges that could impact the cannabis industry.
- Market volatility affecting the performance of cannabis-related stocks.
- Liquidity concerns due to the ETF's small market capitalization.
What Are the Growth Opportunities for HMLSF?
- Regulatory Expansion: As more states and provinces consider legalization, the cannabis market is expected to expand significantly. Analysts predict that the U.S. cannabis market could reach $30 billion by 2025, driven by both medical and recreational use. HMLSF stands to benefit from this growth as it encompasses a wide range of companies involved in the sector.
- Increased Consumer Demand: The rising acceptance of cannabis products among consumers is driving demand. The global cannabis market is anticipated to grow at a CAGR of 23.9% from 2021 to 2028. HMLSF's diversified approach allows investors to capture this growth across various segments, including wellness products and recreational use.
- Technological Advancements: Innovations in cannabis cultivation and processing technologies are enhancing efficiency and product quality. The global cannabis technology market is expected to grow significantly, with HMLSF positioned to benefit from companies that adopt these advancements, leading to improved profitability.
- International Market Entry: As countries around the world begin to legalize cannabis, international opportunities are emerging. HMLSF's diversified portfolio may include companies looking to expand into international markets, potentially increasing their revenue streams and growth prospects.
- Evolving Product Offerings: The cannabis industry is witnessing an increase in product variety, including edibles, beverages, and health-related products. This diversification is expected to attract a broader consumer base, further driving market growth. HMLSF's exposure to a range of companies allows it to capitalize on these trends.
What Opportunities Does HMLSF Have?
- Potential for significant growth as legalization expands.
- Increasing consumer demand for cannabis products.
- Emerging international markets for cannabis.
What Threats Does HMLSF Face?
- Ongoing regulatory challenges that could impact the industry.
- Market volatility affecting investor sentiment.
- Competition from other investment vehicles targeting cannabis.
What Are HMLSF's Competitive Advantages?
- Diversified portfolio reduces risk associated with individual stock volatility.
- Quarterly rebalancing keeps the fund aligned with market leaders.
- Focus on a niche market with significant growth potential.
What Does HMLSF Do?
The Global X Marijuana Life Sciences Index ETF (HMLSF), commonly referred to as HMMJ, is designed to closely follow the performance of the North American Marijuana Index. This index includes a diverse range of publicly traded companies that are significantly engaged in the cannabis industry across North America. The ETF was established to provide investors with a comprehensive exposure to the burgeoning cannabis market, which has seen substantial growth due to increasing legalization and acceptance of cannabis products. HMLSF allows investors to benefit from the growth of the cannabis sector without the risks tied to investing in individual companies. The fund's portfolio is rebalanced quarterly to ensure it reflects the latest market dynamics and leadership changes within the industry. This strategic approach helps the ETF maintain a relevant and competitive position in the fast-evolving cannabis landscape. HMLSF does not pay dividends, and its operational expenses are factored into its aim to replicate the index's returns. The fund is headquartered in Toronto, Canada, and serves a growing base of investors interested in capitalizing on the potential of the cannabis industry, which encompasses cultivation, manufacturing, and distribution of cannabis products.
What Products and Services Does HMLSF Offer?
- Track the performance of the North American Marijuana Index.
- Provide diversified exposure to publicly traded cannabis companies.
- Mitigate risks associated with investing in individual cannabis stocks.
- Undergo quarterly rebalancing to reflect market changes.
- Strive to replicate the index's returns, factoring in operational expenses.
How Does HMLSF Make Money?
- Earn management fees from the assets under management.
- Facilitate investment in a diversified portfolio of cannabis companies.
- Provide investors with a vehicle for exposure to the cannabis sector without individual stock risks.
What Industry Does HMLSF Operate In?
The cannabis industry has experienced rapid growth, driven by increasing legalization and changing consumer perceptions regarding cannabis use. The North American marijuana market is projected to reach approximately $41.5 billion by 2025, reflecting a compound annual growth rate (CAGR) of around 14%. HMLSF operates within this dynamic environment, providing investors with diversified exposure to a range of companies involved in various aspects of the cannabis supply chain, including cultivation, processing, and distribution. The competitive landscape includes a mix of established players and emerging startups, making it a vibrant space for investment.
Who Are HMLSF's Key Customers?
- Institutional investors seeking exposure to the cannabis market.
- Retail investors interested in diversified cannabis investments.
- Financial advisors looking for sector-specific investment options.
How Global X Marijuana Life Sciences Index ETF Is Valued
Relative to its peer group, HMLSF's quantitative score of 44/100 is below the peer average of 65/100.
HMLSF Financials
Bull Case vs Bear Case
Bull Case
- Recent insider activity suggests confidence in the sector's long-term prospects, signaling potential undervaluation.
- The ETF offers diversified exposure to the growing cannabis life sciences industry, mitigating risk associated with individual companies.
- Positive community sentiment indicates strong belief in the future growth of the cannabis market, driving investor interest.
- Market perception is shifting towards increased acceptance and legalization of cannabis, creating new opportunities for growth.
Bear Case
- Regulatory uncertainty surrounding cannabis legalization continues to pose a significant risk to the industry's growth.
- Negative community sentiment highlights concerns about the ETF's performance amid market volatility and sector-specific challenges.
- Intense competition within the cannabis industry could pressure profit margins and limit the ETF's upside potential.
- Market perception is influenced by negative news related to specific companies within the ETF, impacting overall investor confidence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
HMLSF Latest News
No recent news available for HMLSF.
HMLSF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HMLSF.
Price Targets
Wall Street price target analysis for HMLSF.
HMLSF MoonshotScore
What does this score mean?
The MoonshotScore rates HMLSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: David Kunselman
CEO
David Kunselman has extensive experience in the financial services industry, with a focus on asset management and investment strategies. He holds a degree in Finance from a recognized university and has held various leadership roles in asset management firms prior to joining Global X. His expertise in managing diversified portfolios has been instrumental in shaping the fund's strategic direction.
Track Record: Under David Kunselman's leadership, the Global X Marijuana Life Sciences Index ETF has successfully navigated the complexities of the cannabis market, maintaining a diversified portfolio that adapts to changing market dynamics. His strategic decisions have positioned the fund to capture growth opportunities in the evolving cannabis landscape.
HMLSF OTC Market Information
The OTC Other tier includes securities that do not meet the requirements for higher tiers like NYSE or NASDAQ. These stocks may have less stringent reporting requirements, which can affect transparency and investor confidence. However, they also provide access to a wider range of investment opportunities, particularly in niche markets like cannabis.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial reporting may lead to uncertainty regarding the fund's performance.
- Lower liquidity compared to major exchanges can hinder trading efficiency.
- Potential for higher volatility in the OTC market affecting price stability.
- Verify the ETF's performance history and management fees.
- Assess the fund's portfolio composition and diversification.
- Review any available financial statements or reports.
- Understand the regulatory environment affecting the cannabis sector.
- Monitor trading volume and liquidity conditions.
- Established management team with experience in asset management.
- Clear investment strategy focused on the cannabis sector.
- Quarterly rebalancing practices to maintain portfolio relevance.
HMLSF Financial Services Stock FAQ
What does Global X Marijuana Life Sciences Index ETF do?
The Global X Marijuana Life Sciences Index ETF (HMLSF) tracks the performance of the North American Marijuana Index, providing investors with diversified exposure to publicly traded companies in the cannabis sector. This ETF helps mitigate risks associated with individual stock investments while capturing potential growth in the rapidly evolving cannabis market.
What do analysts say about HMLSF stock?
Analysts generally view HMLSF as a unique investment vehicle that offers exposure to the cannabis sector. Key valuation metrics include its market capitalization of approximately $0.03 billion and the absence of a dividend yield, which focuses on capital appreciation. Analysts highlight the ETF's diversified approach as a strength, especially in a volatile market.
What are the main risks for HMLSF?
HMLSF faces several risks, including regulatory challenges that could impact the cannabis industry and market volatility that may affect the performance of cannabis-related stocks. Additionally, its small market capitalization raises liquidity concerns, potentially leading to wider bid-ask spreads and trading difficulties. Investors should be aware of these factors when considering an investment in this ETF.
What are the key factors to evaluate for HMLSF?
Global X Marijuana Life Sciences Index ETF (HMLSF) holds an AI score of 44/100 (low). Not financial advice.
How frequently does HMLSF data refresh on this page?
HMLSF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven HMLSF's recent stock price performance?
Global X Marijuana Life Sciences Index ETF (HMLSF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified exposure to the cannabis sector mitigates individual stock risks. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HMLSF overvalued or undervalued right now?
Valuing Global X Marijuana Life Sciences Index ETF (HMLSF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying HMLSF?
Before investing in Global X Marijuana Life Sciences Index ETF (HMLSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on the latest available information as of June 2026.